enVVeno Medical (NVNO) Share-based Compensation (2017 - 2026)

enVVeno Medical's Share-based Compensation history runs 10 years deep, the most recent figure standing at $467000.0 for Q1 2026.

• In Q1 2026, Share-based Compensation fell 28.26% year-over-year to $467000.0; the TTM figure through Mar 2026 stood at $3.2 million (down 12.67% YoY), while the FY2025 annual figure was $3.4 million, down 17.41% from the prior year.
• Share-based Compensation was $467000.0 for Q1 2026 at enVVeno Medical, down from $637000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $2.3 million in Q2 2022 to a low of $467000.0 in Q1 2026.
• Historically, Share-based Compensation has averaged $1.3 million across 5 years, with a median of $1.1 million in 2024.
• Biggest YoY gain for Share-based Compensation was 1638.76% in 2022; the steepest drop was 58.11% in 2022.
• A 5-year view of Share-based Compensation shows it stood at $2.2 million in 2022, then tumbled by 48.88% to $1.1 million in 2023, then decreased by 11.01% to $1.0 million in 2024, then tumbled by 37.43% to $637000.0 in 2025, then retreated by 26.69% to $467000.0 in 2026.
• The last three Share-based Compensation figures came in at $467000.0 (Q1 2026), $637000.0 (Q4 2025), and $700000.0 (Q3 2025), per Business Quant data.